Requisite Capital Management’s 9 Meters Biopharma NMTR Stock Holding History

Requisite Capital Management’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,000	Closed	-$180	–	95
2023 Q3	$180	Hold	15,000	–	–	﹤0.01%	81
2023 Q2	$10.1K	Hold	15,000	–	–	﹤0.01%	74
2023 Q1	$20.9K	Buy	+15,000	New	+$28.3K	0.01%	67
2022 Q4	–	Sell	-15,000	Closed	-$65K	–	73
2022 Q3	$65K	Buy	+15,000	New	+$74.3K	0.02%	57

Requisite Capital Management's NMTR Position: Q4 2023 in Review

Requisite Capital Management sold out of 9 Meters Biopharma (NMTR) in Q4 2023, closing a stake of 15,000 shares — an estimated $180 sold.

Requisite Capital Management first reported a position in NMTR in Q3 2022 and held it in 4 quarters. The position peaked at $65K in Q3 2022. 1 fund tracked by Wall St. Rank holds NMTR as of Q4 2023.

Requisite Capital Management reported no remaining 9 Meters Biopharma position as of Q4 2023 after selling out during the quarter.
Requisite Capital Management sold 15,000 9 Meters Biopharma shares in Q4 2023, an estimated $180.
Requisite Capital Management first reported a position in 9 Meters Biopharma in Q3 2022 and held it in 4 quarters.
Requisite Capital Management's 9 Meters Biopharma position peaked at $65K in Q3 2022.
1 fund tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2023.

Based on Requisite Capital Management's 13F filing for Q4 2023, filed 23 Jan 2024.